OHSU

IRB #

IRB00003892

Title

[STEM CELLS] Histocompatible human pluripotent cells

Principal Investigator

Shoukhrat Mitalipov

Study Purpose

The purpose of this study is to generate important new insights concerning the feasibility and efficiency of developing patient matched stem cells using novel experimental approaches. In addition we intend to study properties of such stem cells and their utility as a source of cells and tissues for regenerative medicine

Medical Condition(s)

Mitochondrial DNA mutations, Parkinson's disease, Diabetes, motor neuron disease

Eligibility Criteria

Women undergoing infertility treatments at OHSU IVF clinic and willing to donate their abnormal eggs and/or embryos created that cannot be used for infertility treatment and are routinely discarded. In addition, patients who choose to donate their healthy eggs and/or embryos for research can also participate in this study. Egg donors willing to donate their eggs will be also recruited. The age range of potential subjects include women from 21 to 35 years old.


Patients between the ages of 18 and 75 with mitochondrial DNA disease, type I diabetes, motor neuron disease (amyotrophic lateral sclerosis) or Parkinson's disease will be recruited to donate their skin samples for this study.

Age Range

0 - 75

Healthy Volunteers Needed

Yes

Duration of Participation

2 weeks

Minors Included

No

Contact

OHSU Women's Health Research Unit
(503) 494-3666

Sponsor

This study is currently supported by several non federal funds. These include:

1. Funds for Research, Development @ Administration (RDA) from the office of the vice President of OSHU for Research

2. Office of Technology Research Collaborations pursued funds and contract from a Venture Capitalist

Grant applications to private foundations (such as Keck foundation, March of Dimes, United Mitochondrial Disease Foundation) and pursuit of private donations is anticipated to provide funds in the future.

Recruitment End

04/13/2016

Compensation Provided

Yes

Compensation

There will be no compensation for patients undergoing IVF treatment who is willing to donate their excess eggs or embryos for this study.

However, we will compensate healthy egg donors willing to donate their eggs for research. Financial compensation for donation of oocytes for research is ethically justified. Compensation will be for the time, effort, discomfort and inconvenience associated with the oocyte donation process and not for the oocytes themselves.Payment amounts will not exceed amounts considered appropriate for oocyte donation for fertility purposes ( $5,000).

Qualified skin donor participants will be reimbursed $50 for travel and other expenses incurred.


Go Back